1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Exenatide Acetate Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Exenatide Acetate by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Exenatide Acetate by Country/Region, 2018, 2022 & 2029
2.2 Exenatide Acetate Segment by Type
2.2.1 Min Purity Less Than 98%
2.2.2 Min Purity 98%-99%
2.2.3 Min Purity More Than 99%
2.3 Exenatide Acetate Sales by Type
2.3.1 Global Exenatide Acetate Sales Market Share by Type (2018-2023)
2.3.2 Global Exenatide Acetate Revenue and Market Share by Type (2018-2023)
2.3.3 Global Exenatide Acetate Sale Price by Type (2018-2023)
2.4 Exenatide Acetate Segment by Application
2.4.1 Research
2.4.2 Medical
2.5 Exenatide Acetate Sales by Application
2.5.1 Global Exenatide Acetate Sale Market Share by Application (2018-2023)
2.5.2 Global Exenatide Acetate Revenue and Market Share by Application (2018-2023)
2.5.3 Global Exenatide Acetate Sale Price by Application (2018-2023)
3 Global Exenatide Acetate by Company
3.1 Global Exenatide Acetate Breakdown Data by Company
3.1.1 Global Exenatide Acetate Annual Sales by Company (2018-2023)
3.1.2 Global Exenatide Acetate Sales Market Share by Company (2018-2023)
3.2 Global Exenatide Acetate Annual Revenue by Company (2018-2023)
3.2.1 Global Exenatide Acetate Revenue by Company (2018-2023)
3.2.2 Global Exenatide Acetate Revenue Market Share by Company (2018-2023)
3.3 Global Exenatide Acetate Sale Price by Company
3.4 Key Manufacturers Exenatide Acetate Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Exenatide Acetate Product Location Distribution
3.4.2 Players Exenatide Acetate Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Exenatide Acetate by Geographic Region
4.1 World Historic Exenatide Acetate Market Size by Geographic Region (2018-2023)
4.1.1 Global Exenatide Acetate Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Exenatide Acetate Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Exenatide Acetate Market Size by Country/Region (2018-2023)
4.2.1 Global Exenatide Acetate Annual Sales by Country/Region (2018-2023)
4.2.2 Global Exenatide Acetate Annual Revenue by Country/Region (2018-2023)
4.3 Americas Exenatide Acetate Sales Growth
4.4 APAC Exenatide Acetate Sales Growth
4.5 Europe Exenatide Acetate Sales Growth
4.6 Middle East & Africa Exenatide Acetate Sales Growth
5 Americas
5.1 Americas Exenatide Acetate Sales by Country
5.1.1 Americas Exenatide Acetate Sales by Country (2018-2023)
5.1.2 Americas Exenatide Acetate Revenue by Country (2018-2023)
5.2 Americas Exenatide Acetate Sales by Type
5.3 Americas Exenatide Acetate Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Exenatide Acetate Sales by Region
6.1.1 APAC Exenatide Acetate Sales by Region (2018-2023)
6.1.2 APAC Exenatide Acetate Revenue by Region (2018-2023)
6.2 APAC Exenatide Acetate Sales by Type
6.3 APAC Exenatide Acetate Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Exenatide Acetate by Country
7.1.1 Europe Exenatide Acetate Sales by Country (2018-2023)
7.1.2 Europe Exenatide Acetate Revenue by Country (2018-2023)
7.2 Europe Exenatide Acetate Sales by Type
7.3 Europe Exenatide Acetate Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Exenatide Acetate by Country
8.1.1 Middle East & Africa Exenatide Acetate Sales by Country (2018-2023)
8.1.2 Middle East & Africa Exenatide Acetate Revenue by Country (2018-2023)
8.2 Middle East & Africa Exenatide Acetate Sales by Type
8.3 Middle East & Africa Exenatide Acetate Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Exenatide Acetate
10.3 Manufacturing Process Analysis of Exenatide Acetate
10.4 Industry Chain Structure of Exenatide Acetate
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Exenatide Acetate Distributors
11.3 Exenatide Acetate Customer
12 World Forecast Review for Exenatide Acetate by Geographic Region
12.1 Global Exenatide Acetate Market Size Forecast by Region
12.1.1 Global Exenatide Acetate Forecast by Region (2024-2029)
12.1.2 Global Exenatide Acetate Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Exenatide Acetate Forecast by Type
12.7 Global Exenatide Acetate Forecast by Application
13 Key Players Analysis
13.1 Bachem
13.1.1 Bachem Company Information
13.1.2 Bachem Exenatide Acetate Product Portfolios and Specifications
13.1.3 Bachem Exenatide Acetate Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Bachem Main Business Overview
13.1.5 Bachem Latest Developments
13.2 Cayman Chemical
13.2.1 Cayman Chemical Company Information
13.2.2 Cayman Chemical Exenatide Acetate Product Portfolios and Specifications
13.2.3 Cayman Chemical Exenatide Acetate Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Cayman Chemical Main Business Overview
13.2.5 Cayman Chemical Latest Developments
13.3 Santa Cruz Biotechnology
13.3.1 Santa Cruz Biotechnology Company Information
13.3.2 Santa Cruz Biotechnology Exenatide Acetate Product Portfolios and Specifications
13.3.3 Santa Cruz Biotechnology Exenatide Acetate Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Santa Cruz Biotechnology Main Business Overview
13.3.5 Santa Cruz Biotechnology Latest Developments
13.4 BOC Sciences
13.4.1 BOC Sciences Company Information
13.4.2 BOC Sciences Exenatide Acetate Product Portfolios and Specifications
13.4.3 BOC Sciences Exenatide Acetate Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 BOC Sciences Main Business Overview
13.4.5 BOC Sciences Latest Developments
13.5 Selleck Chemicals
13.5.1 Selleck Chemicals Company Information
13.5.2 Selleck Chemicals Exenatide Acetate Product Portfolios and Specifications
13.5.3 Selleck Chemicals Exenatide Acetate Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Selleck Chemicals Main Business Overview
13.5.5 Selleck Chemicals Latest Developments
13.6 Clearsynth
13.6.1 Clearsynth Company Information
13.6.2 Clearsynth Exenatide Acetate Product Portfolios and Specifications
13.6.3 Clearsynth Exenatide Acetate Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Clearsynth Main Business Overview
13.6.5 Clearsynth Latest Developments
13.7 United States Biological
13.7.1 United States Biological Company Information
13.7.2 United States Biological Exenatide Acetate Product Portfolios and Specifications
13.7.3 United States Biological Exenatide Acetate Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 United States Biological Main Business Overview
13.7.5 United States Biological Latest Developments
13.8 Biosynth Carbosynth
13.8.1 Biosynth Carbosynth Company Information
13.8.2 Biosynth Carbosynth Exenatide Acetate Product Portfolios and Specifications
13.8.3 Biosynth Carbosynth Exenatide Acetate Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Biosynth Carbosynth Main Business Overview
13.8.5 Biosynth Carbosynth Latest Developments
13.9 LGC
13.9.1 LGC Company Information
13.9.2 LGC Exenatide Acetate Product Portfolios and Specifications
13.9.3 LGC Exenatide Acetate Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 LGC Main Business Overview
13.9.5 LGC Latest Developments
13.10 BioCrick BioTech
13.10.1 BioCrick BioTech Company Information
13.10.2 BioCrick BioTech Exenatide Acetate Product Portfolios and Specifications
13.10.3 BioCrick BioTech Exenatide Acetate Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 BioCrick BioTech Main Business Overview
13.10.5 BioCrick BioTech Latest Developments
14 Research Findings and Conclusion
※参考情報 酢酸エクセナチド(Exenatide Acetate)は、糖尿病治療に用いられる医薬品で、グルカゴン様ペプチド-1(GLP-1)受容体作動薬の一種です。主に2型糖尿病患者に対して血糖コントロールを改善する目的で使用されます。エクセナチドは、もともとサソリの唾液腺から発見されたペプチドの一種で、体内におけるインスリン分泌を促進し、血糖値を低下させる働きがあります。 エクセナチドは、体内におけるGLP-1ホルモンの効果を模倣するものであり、このホルモンは食事に応答してインスリンの分泌を促進し、グルカゴンの分泌を抑制します。また、胃の排出を遅らせることで食欲を抑える効果も持っています。このため、糖尿病の治療だけでなく、体重管理にも寄与することが期待されています。 酢酸エクセナチドの主な特徴としては、効果の持続時間があります。他の経口糖尿病薬に比べて、持続的なインスリン分泌を促す効果があり、1日1回または1日2回の投与が一般的です。また、皮下注射によって投与されるため、患者の自己管理が必要となりますが、これにより胃腸障害などの副作用を避けつつ効果的なコントロールが可能となります。 エクセナチドには主に2つの製剤があります。1つは短時間作用型で、急速に効果を発揮するため、食事前の投与が推奨されます。もう1つは長時間作用型で、持続的な血糖コントロールが期待できるため、1日の特定の時間に定期的に投与されます。これにより、患者は自分の日常生活に合わせた投与計画を立てることができます。 用途としては、主に2型糖尿病患者における血糖コントロールが挙げられますが、過去の研究では体重減少に対する効果も示されています。特に、肥満を伴う2型糖尿病患者においては、体重の減少が血糖コントロールを助けるため、エクセナチドの使用が推奨されることがあります。また、一部の研究では、心血管疾患のリスクを低下させる可能性も示唆されており、心血管保護に関する臨床的意義についての関心が高まっています。 関連技術としては、注射剤の製造プロセスや投与装置の技術が挙げられます。特に、患者が自宅で簡便に自己注射を行うことができるように、使いやすいペン型の注射器が広く用いられています。さらに、糖尿病管理システムやテクノロジーの進化により、血糖測定機やインスリンポンプと連携して使用されることもあります。 副作用については、一般的に軽度から中等度のもので、最も多く報告されるものは消化器系の症状です。具体的には、吐き気や嘔吐、下痢、腹痛などが挙げられます。ただし、これらの症状は一般的に時間とともに改善することが多いとされています。稀に、重篤な副作用として膵炎が報告されていますので、使用中の患者は注意が必要です。 結論として、酢酸エクセナチドは2型糖尿病に対する重要な治療選択肢の一つであり、その特性や種類を把握することで、より効果的な治療を行うことができるかと思います。常に新しい研究や治験が進められており、今後もその有効性や安全性に関する知見が深化することが期待されています。糖尿病は生活習慣と深く関連している疾患であり、エクセナチドのような薬剤とともに、患者自身の生活改善への取り組みが大切です。 |